01 Jun 2026
9min read
Contents
Author

Around 50% of UK men show visible hair thinning by age 50 and roughly 80% by age 70. Most of it is androgenetic alopecia — male pattern hair loss — a hereditary, hormonally-driven condition that is well-understood and well-treatable. The treatments that work are limited but genuine. The treatments that don't work are everywhere.
This guide is the LYV Clinical Team's honest summary, written to save you time and money on the things that don't deliver. If you are comparing hair loss treatment UK men options, the most important starting point is understanding whether your hair loss is male pattern hair loss, temporary shedding, nutritional deficiency, stress-related loss, or another scalp condition.
LYV also has related guides on hair loss causes, myths and what actually works, clinically backed hair growth treatment in 2026, and hair loss vs hair thinning.
For most men with male pattern hair loss, the evidence-based core is simple: finasteride helps reduce the hormonal driver behind follicle miniaturisation, while minoxidil supports the growth environment of the follicle. They work differently, which is why they are often discussed together.
That does not mean every man needs both from day one. Some men start with one treatment because of preference, side-effect concerns, routine, cost, or clinical suitability. Others choose combination therapy because their hair loss is active and they want the strongest realistic chance of stabilising shedding and preserving density.

Androgenetic alopecia is the gradual miniaturisation of hair follicles in the scalp, driven by their genetically-coded sensitivity to dihydrotestosterone (DHT) — a derivative of testosterone produced by the enzyme 5-alpha reductase.
The follicles do not disappear straight away. They shrink, producing thinner, shorter hairs over each growth cycle, until eventually the hair becomes vellus hair — often described as peach-fuzz — and the area looks bald.
The pattern of loss — receding hairline, crown thinning, eventual horseshoe ring of remaining hair — reflects the distribution of DHT-sensitive follicles. This is why male pattern hair loss often follows a predictable shape rather than affecting the whole scalp evenly.
Two practical points follow from this. First, the treatment that works long-term has to address either DHT or the follicle environment, not the hair shaft itself. Second, the earlier you intervene, the more follicles you have to preserve. Hair lost for years is harder to recover; hair currently miniaturising is easier to keep.
Not every man losing hair has classic male pattern hair loss. Some men experience temporary shedding after illness, rapid weight change, stress, nutritional deficiency, medication changes, or scalp inflammation. That is why a proper assessment matters before starting treatment.
Male pattern hair loss usually develops gradually around the temples, frontal hairline, or crown. Sudden patchy loss, scalp pain, scaling, redness, or rapid shedding across the whole scalp should be discussed with a clinician because the cause may be different.

Two treatments are licensed in the UK with robust evidence: finasteride, which is oral and prescription-only, and minoxidil, which is topical and available over the counter and on prescription. Used together, they cover most patients well. Used in isolation, each is meaningfully less effective.
Finasteride blocks 5-alpha reductase and reduces scalp DHT by around 60%. Roughly 90% of men who take it show stabilisation of their hair loss within 12 months, and around two-thirds show some regrowth.
It is usually taken once a day. Side effects are uncommon but do exist — sexual side effects such as reduced libido or erectile dysfunction in around 1–2% of men, and mood changes in some. Most resolve on stopping. Men who are worried about side effects should raise this during the consultation so the prescriber can explain the benefit-risk balance clearly.
Minoxidil works through a different and not fully understood mechanism, primarily by extending the hair follicle's growth phase and increasing follicle size. It is applied as a 5% topical solution or foam to the scalp.
Around 60% of men who use it consistently for 6 months see some improvement. The biggest barrier to its effectiveness is consistency — it has to be applied every day, indefinitely, and most men who “try” minoxidil and conclude it does not work have used it inconsistently or stopped before results could reasonably appear.
Finasteride and minoxidil are not direct substitutes. They work on different parts of the hair-loss process. Finasteride targets the DHT pathway that drives male pattern hair loss, while minoxidil supports follicles and helps prolong the growth phase.
If a man wants to target the underlying hormonal driver, finasteride is usually the more direct treatment. If he wants a non-hormonal topical option, minoxidil is usually the better starting point. For men with active thinning who are comfortable with both treatments, combination therapy is often the most complete approach.

The two drugs work on different mechanisms. Finasteride reduces the underlying hormonal driver; minoxidil supports the follicles directly. Trial data and clinic experience consistently show that combining them produces better outcomes than either alone, and that combination users are more likely to maintain or improve their hair density at 2- and 5-year follow-up.
Most LYV pharmacists recommend starting both together if hair loss is active and the patient is comfortable with both routes. That said, a good treatment plan should still fit real life. A treatment that is clinically strong but too inconvenient to use consistently will not perform well over time.
Dutasteride is a more potent 5-alpha reductase inhibitor than finasteride. It reduces scalp DHT by around 90% versus 60%. It is licensed in the UK for benign prostatic hyperplasia but not for hair loss, meaning its hair-loss use is off-label and is usually reserved for men whose response to finasteride is incomplete after a year.
The side-effect profile is similar to finasteride but slightly higher in some categories. Dutasteride should only be used under specialist supervision.
Hair transplant surgery, especially FUE or follicular unit extraction, is now a mature technique with reliable results when done by a competent surgeon. It is not a substitute for medical therapy. Without finasteride or minoxidil to protect the surrounding native hair, transplanted hair can sit in an increasingly bald scalp over time.
Used in combination with medical treatment, transplant surgery can be transformative for men with established hair loss.
Most hair-loss shampoos. Most over-the-counter “hair vitamins” — although some may help mild deficiencies, they do not treat androgenetic alopecia. Most laser caps and combs in their consumer-grade forms. There is some evidence for clinical-grade low-level laser therapy under specialist supervision, but the consumer market is largely unregulated.
PRP or platelet-rich plasma injections have emerging but mixed evidence, are expensive, and do not replace finasteride and minoxidil. Scalp massagers may feel good, but they should not be treated as standalone male pattern hair loss treatment.
The point is not that every non-medical product is dangerous. Many are harmless. The point is that they can consume money, time and attention that would be better spent on the two treatments that genuinely work.
The earlier the better. Hair follicles that are actively miniaturising are easier to preserve than follicles that have been lost for years. If you can see your hairline receding or your crown thinning compared to two years ago, that is the right time to speak to a clinician.
Waiting until the loss is obvious to others is waiting too long. The decision to treat is reversible — you can stop at any time, though you will lose treatment-dependent gains within 6–12 months of stopping.

Hair grows slowly, so hair loss treatment needs patience. Stabilisation is usually the first realistic goal. Regrowth, if it happens, normally follows later.
Many men stop too early because they expect visible change in a few weeks. That is not how follicle cycles work. A fair trial usually means several months of consistent use, with comparison photos taken under the same lighting and angle.

LYV offers a discreet online consultation reviewed by a GPhC-registered prescriber. Generic finasteride 1 mg, topical minoxidil 5%, and combinations are dispensed in plain packaging. There is no subscription; you order each cycle as you need it.
The consultation captures the relevant medical history, screens for the small number of contraindications, and gives the prescriber the information they need to recommend either treatment alone or both together.
If you are comparing options, you can also review LYV’s transparent pharmacy pricing, read about private online pharmacy safety, or check the LYV FAQs for common questions about online treatment, shipping and clinical support.
LYV's online assessment takes around 5 minutes. Reviewed by a UK GPhC-registered prescriber. Plain-packaged dispatch the next working day.
If treatment is suitable, the LYV Clinical Team can recommend finasteride, minoxidil, or a combination plan based on your hair-loss pattern, medical history and treatment preferences.
This article is general information for UK adults and is not a substitute for personalised medical advice. Prescription-only medicines mentioned are dispensed only after a clinician-led online consultation through LYV Pharmacy (GPhC registration 9012803). If you have concerns about your symptoms or any medication you are taking, speak to your GP or call NHS 111.